Literature DB >> 6618438

Diagnostic effectiveness of serum bile acids in liver diseases as evaluated by multivariate statistical methods.

D Festi, A M Morselli Labate, A Roda, F Bazzoli, R Frabboni, P Rucci, F Taroni, R Aldini, E Roda, L Barbara.   

Abstract

The aims of this study were to determine the diagnostic effectiveness of fasting and postprandial serum bile acid determinations in liver diseases, and to compare results with those of conventional liver function tests. In 322 patients with biopsy-proved liver disease and 93 healthy subjects, fasting and postprandial (2 hr) serum levels of cholic, chenodeoxycholic, and lithocholic acid conjugates and conventional liver function tests were evaluated. Data were subjected to variance and discriminant and factor analyses. Fasting serum bile acids were higher in patients when compared to controls and were significantly higher in severe than in mild liver diseases. Determination of cholic plus lithocholic acid provided the highest discrimination capacity. The percent of correct allocation was 75.4% for conventional liver function tests, 70.1% for fasting serum bile acids and increased to 79.6% when liver function tests plus serum bile acids were considered. Postprandial percentages were always lower than fasting. Factor analysis identified two factors possibly related to cytolysis and protein synthesis. The serum bile acid concentrations highly correlated with both factors. We conclude that serum bile acid determinations increase the diagnostic and discriminant capacities of liver function tests and are more sensitive and discriminant when obtained in fasting than postprandially.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6618438     DOI: 10.1002/hep.1840030514

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  15 in total

Review 1.  Fetal and neonatal bile acid synthesis and metabolism--clinical implications.

Authors:  W F Balistreri
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

2.  Lithocholic acid disrupts phospholipid and sphingolipid homeostasis leading to cholestasis in mice.

Authors:  Tsutomu Matsubara; Naoki Tanaka; Andrew D Patterson; Joo-Youn Cho; Kristopher W Krausz; Frank J Gonzalez
Journal:  Hepatology       Date:  2011-04       Impact factor: 17.425

3.  Determinants of hepatic function in liver cirrhosis in the rat. Multivariate analysis.

Authors:  J Reichen; B Egger; N Ohara; T B Zeltner; T Zysset; A Zimmermann
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

4.  Measurement of hepatic functional mass by means of 13C-methacetin and 13C-phenylalanine breath tests in chronic liver disease: comparison with Child-Pugh score and serum bile acid levels.

Authors:  D Festi; S Capodicasa; L Sandri; L Colaiocco-Ferrante; T Staniscia; E Vitacolonna; A Vestito; P Simoni; G Mazzella; P Portincasa; E Roda; A Colecchia
Journal:  World J Gastroenterol       Date:  2005-01-07       Impact factor: 5.742

5.  TGF-β-SMAD3 signaling mediates hepatic bile acid and phospholipid metabolism following lithocholic acid-induced liver injury.

Authors:  Tsutomu Matsubara; Naoki Tanaka; Misako Sato; Dong Wook Kang; Kristopher W Krausz; Kathleen C Flanders; Kazuo Ikeda; Hans Luecke; Lalage M Wakefield; Frank J Gonzalez
Journal:  J Lipid Res       Date:  2012-10-03       Impact factor: 5.922

6.  Bile acids modulate glucocorticoid metabolism and the hypothalamic-pituitary-adrenal axis in obstructive jaundice.

Authors:  Alison D McNeilly; David P Macfarlane; Emmett O'Flaherty; Dawn E Livingstone; Tijana Mitić; Kirsty M McConnell; Scott M McKenzie; Eleanor Davies; Rebecca M Reynolds; Helle C Thiesson; Ole Skøtt; Brian R Walker; Ruth Andrew
Journal:  J Hepatol       Date:  2010-03-04       Impact factor: 25.083

7.  Value of serum determinations for prediction of increased ursodeoxycholic and chenodeoxycholic levels in bile.

Authors:  F Bazzoli; H Fromm; A Roda; A K Tunuguntla; E Roda; L Barbara; P Amin
Journal:  Dig Dis Sci       Date:  1985-07       Impact factor: 3.199

8.  Serum concentrations of laminin in cirrhosis of the liver.

Authors:  J Collazos; F Díaz; J Genollá
Journal:  Gut       Date:  1993-07       Impact factor: 23.059

9.  Diagnostic value of serum immunoreactive conjugated cholic or chenodeoxycholic acids in detecting hepatobiliary diseases. Comparison with levels of 3 alpha-hydroxy bile acids determined enzymatically and with routine liver tests.

Authors:  R Ferraris; M T Fiorentini; G Galatola; P Rolfo; M De la Pierre
Journal:  Dig Dis Sci       Date:  1987-08       Impact factor: 3.199

10.  Glycocholic acid in chronic active hepatitis and mild liver diseases.

Authors:  J Collazos
Journal:  Clin Investig       Date:  1993-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.